Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China.
Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.
Ann Surg Oncol. 2024 Apr;31(4):2679-2688. doi: 10.1245/s10434-023-14808-2. Epub 2023 Dec 23.
Robotic gastrectomy (RG) has been widely used to treat gastric cancer. However, whether the short-term outcomes of robotic gastrectomy are superior to those of laparoscopic gastrectomy (LG) for elderly patients with advanced gastric cancer has not been reported.
The study enrolled of 594 elderly patients with advanced gastric cancer who underwent robotic or laparoscopic radical gastrectomy. The RG cohort was matched 1:3 with the LG cohort using propensity score-matching (PSM).
After PSM, 121 patients were included in the robot group and 363 patients in the laparoscopic group. Excluding the docking and undocking times, the operation time of the two groups was similar (P = 0.617). The RG group had less intraoperative blood loss than the LG group (P < 0.001). The time to ambulation and first liquid food intake was significantly shorter in the RG group than in the LG group (P < 0.05). The incidence of postoperative complications did not differ significantly between the two groups (P = 0.14). Significantly more lymph nodes were dissected in the RG group than in the LG group (P = 0.001). Postoperative adjuvant chemotherapy was started earlier in the RG group than in the LG group (P = 0.02).
For elderly patients with advanced gastric cancer, RG is safe and feasible. Compared with LG, RG is associated with less intraoperative blood loss; a faster postoperative recovery time, allowing a greater number of lymph nodes to be dissected; and earlier adjuvant chemotherapy.
机器人胃切除术(RG)已广泛用于治疗胃癌。然而,对于老年进展期胃癌患者,机器人胃切除术的短期疗效是否优于腹腔镜胃切除术(LG)尚未报道。
本研究纳入了 594 例行机器人或腹腔镜根治性胃切除术的老年进展期胃癌患者。使用倾向评分匹配(PSM)将 RG 组与 LG 组进行 1:3 匹配。
PSM 后,机器人组纳入 121 例,腹腔镜组纳入 363 例。排除对接和脱机时间后,两组的手术时间相似(P=0.617)。机器人组术中出血量少于腹腔镜组(P<0.001)。机器人组下床活动时间和首次进液时间均明显短于腹腔镜组(P<0.05)。两组术后并发症发生率无显著差异(P=0.14)。机器人组淋巴结清扫数明显多于腹腔镜组(P=0.001)。机器人组术后辅助化疗开始时间早于腹腔镜组(P=0.02)。
对于老年进展期胃癌患者,RG 是安全可行的。与 LG 相比,RG 术中出血量较少,术后恢复较快,可切除更多的淋巴结,且辅助化疗开始较早。